These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2027924)

  • 1. Comparison of tetrahydroaminoacridine and physostigmine on scopolamine-induced free swim behavior in the rat.
    Dokla CP; Rydelek-Fitzgerald L
    Psychopharmacology (Berl); 1991; 103(2):240-3. PubMed ID: 2027924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats.
    Murray TK; Cross AJ; Green AR
    Psychopharmacology (Berl); 1991; 105(1):134-6. PubMed ID: 1745706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ameliorative effects of the centrally active cholinesterase inhibitor, NIK-247, on impairment of working memory in rats.
    Yamamoto T; Ohno M; Kitajima I; Yatsugi S; Ueki S
    Physiol Behav; 1993 Jan; 53(1):5-10. PubMed ID: 8434069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine treatment and fimbria-fornix lesions: mimetic effects on radial maze performance.
    Cassel JC; Kelche C
    Physiol Behav; 1989 Sep; 46(3):347-53. PubMed ID: 2623054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
    Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M
    Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tacrine (THA) on spatial reference memory and cholinergic enzymes in specific rat brain regions.
    Jackson JJ; Soliman MR
    Life Sci; 1996; 58(1):47-54. PubMed ID: 8628110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test.
    Mancinelli A; Borsini F; d'Aranno V; Lecci A; Meli A
    Eur J Pharmacol; 1988 Dec; 158(3):199-205. PubMed ID: 3253098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
    Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR
    Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
    Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD
    Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.
    Addy NA; Nunes EJ; Wickham RJ
    Behav Brain Res; 2015 Jul; 288():54-62. PubMed ID: 25865152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic effects on spatial exploration and its memory.
    Kelly PH; Malanowski J
    Can J Physiol Pharmacol; 1993; 71(5-6):352-64. PubMed ID: 8402401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of scopolamine and physostigmine on acquisition of morphine-treated rats in Morris water maze performance.
    Zheng XG; Li XW; Yang XY; Sui N
    Acta Pharmacol Sin; 2002 May; 23(5):477-80. PubMed ID: 11978201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats.
    Yoshida S; Suzuki N
    Eur J Pharmacol; 1993 Nov; 250(1):117-24. PubMed ID: 8119309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning deficits in aged rats pretreated chronically with barbital and tested late in abstinence: alleviation by tetrahydroaminoacridine.
    Mohammed AK; Wahlström G; Archer T; Nordberg A
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):285-94. PubMed ID: 2078308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
    Clarke PB; Reuben M; el-Bizri H
    Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Psychopharmacology (Berl); 1993; 112(4):415-20. PubMed ID: 7871051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat.
    Hallam KT; Horgan JE; McGrath C; Norman TR
    Behav Brain Res; 2004 Aug; 153(2):481-6. PubMed ID: 15265646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat.
    Bassant MH; Jazat F; Lamour Y
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):855-64. PubMed ID: 8360291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats.
    Janas AM; Cunningham SC; Duffy KB; Devan BD; Greig NH; Holloway HW; Yu QS; Markowska AL; Ingram DK; Spangler EL
    Life Sci; 2005 Jan; 76(10):1073-81. PubMed ID: 15620572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.